Medications

Inhalation drug may prevent severe pneumonia

Overly active immune cells are often behind lung damage in diseases such as COVID-19. Researchers at the Technical University of Munich (TUM) have developed an RNA agent for a lung spray that slows the activity of these cells, ...

Medical research

'Decoy' protein works against multiple SARS-CoV-2 variants

A drug treatment that acts as a decoy against SARS-CoV-2 was highly effective at preventing death and lung damage in humanized animal models of severe COVID-19 disease, according to a Nature Chemical Biology study from researchers ...

page 1 from 8